{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:04:25Z","timestamp":1790240665187,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13775-9","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:25:11Z","timestamp":1780914311000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of adding metronidazole to meropenem on clinical efficacy in complicated intra-abdominal infections: a retrospective study"],"prefix":"10.1186","volume":"26","author":[{"given":"Hajime","family":"Nakashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyasu","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoaki","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Maeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Yoshikuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Imakyure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"1","key":"13775_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1749-7922-8-1","volume":"8","author":"M Sartelli","year":"2013","unstructured":"Sartelli M, Catena F, Ansaloni L, Moore E, Malangoni M, et al. Complicated intra-abdominal infections in a worldwide context: an observational prospective study (CIAOW Study). World J Emerg Surg. 2013;8(1):1.","journal-title":"World J Emerg Surg"},{"issue":"2","key":"13775_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1086\/649554","volume":"50","author":"JS Solomkin","year":"2010","unstructured":"Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guide lines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(2):133\u201364.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"13775_CR3","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1080\/00365540903159261","volume":"41","author":"N Newman","year":"2009","unstructured":"Newman N, Wattad E, Greenberg D, Peled N, Cohen Z, Leibovitz E. Community-acquired complicated intra-abdominal infections in children hospitalized during 1995\u20132004 at a paediatric surgery department. Scand J Infect Dis. 2009;41(10):720\u20136.","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"13775_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1749-7922-7-36","volume":"7","author":"M Sartelli","year":"2012","unstructured":"Sartelli M, Catena F, Ansaloni L, Leppaniemi A, Taviloglu K, et al. Complicated intra-abdominal infections in Europe: a comprehensive review of the CIAO study. World J Emerg Surg. 2012;7(1):36.","journal-title":"World J Emerg Surg"},{"issue":"1","key":"13775_CR5","first-page":"72","volume":"6","author":"SH Lob","year":"2017","unstructured":"Lob SH, Badal RE, Hackel MA, Sahm DF. Epidemiology and Antimicrobial Susceptibility of Gram-Negative Pathogens Causing Intra-abdominal Infections in Pediatric Patients in Europe-SMART 2011\u20132014. J Pediatr Infect Dis Soc. 2017;6(1):72\u20139.","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"8","key":"13775_CR6","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1097\/01.CCM.0000087326.59341.51","volume":"31","author":"JC Marshall","year":"2003","unstructured":"Marshall JC, Innes M. Intensive care unit management of intra-abdominal infection. Crit Care Med. 2003;31(8):2228\u201337.","journal-title":"Crit Care Med"},{"issue":"1","key":"13775_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/sur.2016.261","volume":"18","author":"JE Mazuski","year":"2017","unstructured":"Mazuski JE, Tessier JM, May AK, Sawyer RG, Nadler EP, et al. The Surgical infection society revised guidelines on the management of intraabdominal infection. Surg Infect (Larchmt). 2017;18(1):1\u201376.","journal-title":"Surg Infect (Larchmt)"},{"issue":"11","key":"13775_CR8","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1093\/cid\/ciw133","volume":"62","author":"JE Mazuski","year":"2016","unstructured":"Mazuski JE, Gasink LB, Armstrong J, Broadhurst H, Stone GG, Rank D, Llorens L, Newell P, Pachl J. Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program. Clin Infect Dis. 2016;62(11):1380\u20139.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"13775_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/01.SLA.0000048551.32606.73","volume":"237","author":"JS Solomkin","year":"2003","unstructured":"Solomkin JS, Yellin AE, Rotstein OD, Christou NV, Dellinger EP, Tellado JM, Malafaia O, Fernandez A, Choe KA, Carides A, Satishchandran V, Teppler H. Protocol 017 Study Group. Ertapenem versus piperacillin\/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial. Ann Surg. 2003;237(2):235\u201345.","journal-title":"Ann Surg"},{"issue":"8215","key":"13775_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(81)91909-7","volume":"1","author":"J Paavonen","year":"1981","unstructured":"Paavonen J, Valtonen VV, Kasper DL, Malkam\u00e4ki M, M\u00e4kel\u00e4 PH. Serological evidence for the role of Bacteroides fragilis and enterobacteriaceae in the pathogenesis of acute pelvic inflammatory disease. Lancet. 1981;1(8215):293\u20135.","journal-title":"Lancet"},{"issue":"5","key":"13775_CR11","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.21873\/invivo.13703","volume":"38","author":"TK Yeh","year":"2024","unstructured":"Yeh TK, Huang YT, Liu PY, Mao YC, Lai CS, Lai KL, Tseng CH, Liu CW, Huang WH, Huang HP, Lin KP. Pathogenic Detection by Metagenomic Next-generation Sequencing in Skin and Soft Tissue Infection. Vivo. 2024;38(5):2364\u201373.","journal-title":"Vivo"},{"issue":"5","key":"13775_CR12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.7326\/0003-4819-86-5-569","volume":"86","author":"BF Polk","year":"1977","unstructured":"Polk BF, Kasper DL. Bacteroides fragilis subspecies in clinical isolates. Ann Intern Med. 1977;86(5):569\u201371.","journal-title":"Ann Intern Med"},{"issue":"5","key":"13775_CR13","first-page":"360","volume":"19","author":"I Brook","year":"1989","unstructured":"Brook I. Pathogenicity of the Bacteroides fragilis group. Ann Clin Lab Sci. 1989;19(5):360\u201376.","journal-title":"Ann Clin Lab Sci"},{"issue":"5","key":"13775_CR14","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00000658-197711000-00002","volume":"186","author":"PF Lawrence","year":"1977","unstructured":"Lawrence PF, Tietjen GW, Gingrich S, King TC. Bacteroides bacteremia. Ann Surg. 1977;186(5):559\u201363.","journal-title":"Ann Surg"},{"issue":"8","key":"13775_CR15","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1001\/archsurg.1984.01390200014003","volume":"119","author":"CS Bryan","year":"1984","unstructured":"Bryan CS, Reynolds KL, Kirkhart B, Brown JJ. Bacteroides bacteremia. Analysis of 142 episodes from one metropolitan area. Arch Surg. 1984;119(8):894\u20138.","journal-title":"Arch Surg"},{"issue":"Suppl 1","key":"13775_CR16","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1093\/clinids\/23.Supplement_1.S97","volume":"23","author":"EJ Goldstein","year":"1996","unstructured":"Goldstein EJ. Anaerobic bacteremia. Clin Infect Dis. 1996;23(Suppl 1):S97\u2013101.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"13775_CR17","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1086\/313805","volume":"30","author":"MH Nguyen","year":"2000","unstructured":"Nguyen MH, Yu VL, Morris AJ, McDermott L, Wagener MW, Harrell L, Snydman DR. Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin Infect Dis. 2000;30(6):870\u20136.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"13775_CR18","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1469-0691.2005.01214.x","volume":"11","author":"JR Zahar","year":"2005","unstructured":"Zahar JR, Farhat H, Chachaty E, Meshaka P, Antoun S, Nitenberg G. Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6-year retrospective study. Clin Microbiol Infect. 2005;11(9):724\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"13775_CR19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2165\/00003495-200868060-00006","volume":"68","author":"CM Baldwin","year":"2008","unstructured":"Baldwin CM, Lyseng-Williamson KA, Keam SJ, Meropenem. A review of its use in the treatment of serious bacterial infections. Drugs. 2008;68(6):803\u201338.","journal-title":"Drugs"},{"key":"13775_CR20","doi-asserted-by":"publisher","unstructured":"Takesue Y, Kusachi S, Mikamo H, Sato J, Watanabe A, Kiyota H, et al. Antimicrobial susceptibility of pathogens isolated from surgical site infections in Japan: Comparison of data from nationwide surveillance studies conducted in 2010 and 2014\u20132015. J Infect Chemother. 2017;23(6):339\u2013348. https:\/\/doi.org\/10.1016\/j.jiac.2017.03.010. Epub 2017 Apr 5. Erratum in: J Infect Chemother. 2018;24(2):156\u2013157.","DOI":"10.1016\/j.jiac.2017.03.010"},{"issue":"7","key":"13775_CR21","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jiac.2021.03.010","volume":"27","author":"T Ueda","year":"2021","unstructured":"Ueda T, Takesue Y, Matsumoto T, Tateda K, Kusachi S, et al. Change in antimicrobial susceptibility of pathogens isolated from surgical site infections over the past decade in Japanese nation-wide surveillance study. J Infect Chemother. 2021;27(7):931\u20139.","journal-title":"J Infect Chemother"},{"issue":"1\u20132","key":"13775_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0732-8893(95)00104-I","volume":"22","author":"C Aprahamian","year":"1995","unstructured":"Aprahamian C, Schein M, Wittmann D. Cefotaxime and metronidazole in severe intra-abdominal infection. Diagn Microbiol Infect Dis. 1995;22(1\u20132):183\u20138.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"13775_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4174\/astr.2015.89.1.43","volume":"89","author":"JM Bae","year":"2015","unstructured":"Bae JM. Clinical characteristics of ceftriaxone plus metronidazole in complicated intra-abdominal infection. Ann Surg Treat Res. 2015;89(1):43\u20137.","journal-title":"Ann Surg Treat Res"},{"issue":"12","key":"13775_CR24","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1001\/archsurg.1997.01430360040008","volume":"132","author":"PS Barie","year":"1997","unstructured":"Barie PS, Vogel SB, Dellinger EP, Rotstein OD, Solomkin JS, Yang JY, Baumgartner TF. A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group. Arch Surg. 1997;132(12):1294\u2013302.","journal-title":"Arch Surg"},{"issue":"3","key":"13775_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/00000658-199603000-00012","volume":"223","author":"JS Solomkin","year":"1996","unstructured":"Solomkin JS, Reinhart HH, Dellinger EP, Bohnen JM, Rotstein OD, et al. Results of a randomized trial comparing sequential intravenous\/oral treatment with ciprofloxacin plus metronidazole to imipenem\/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group. Ann Surg. 1996;223(3):303\u201315.","journal-title":"Ann Surg"},{"issue":"3","key":"13775_CR26","doi-asserted-by":"publisher","first-page":"107241","DOI":"10.1016\/j.ijantimicag.2024.107241","volume":"64","author":"MEJ Buhl","year":"2024","unstructured":"Buhl MEJ, Sunnerhagen T, Join-Lambert O, Morris T, Jeverica S, et al. Antimicrobial resistance surveillance of Bacteroides fragilis isolated from blood cultures, Europe, 2022 (ReSuBacfrag). Int J Antimicrob Agents. 2024;64(3):107241.","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"13775_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3390\/antibiotics10050479","volume":"10","author":"E K\u00f6nig","year":"2021","unstructured":"K\u00f6nig E, Ziegler HP, Tribus J, Grisold AJ, Feierl G, Leitner E. Surveillance of Antimicrobial Susceptibility of Anaerobe Clinical Isolates in Southeast Austria: Bacteroides fragilis Group Is on the Fast Track to Resistance. Antibiot (Basel). 2021;10(5):479.","journal-title":"Antibiot (Basel)"},{"key":"13775_CR28","doi-asserted-by":"publisher","first-page":"102182","DOI":"10.1016\/j.anaerobe.2020.102182","volume":"62","author":"J S\u00f3ki","year":"2020","unstructured":"S\u00f3ki J, Wybo I, Hajd\u00fa E, Toprak NU, Jeverica S, Stingu CS, Tierney D, Perry JD, Matuz M, Urb\u00e1n E, Nagy E, ESCMID Study Group on Anaerobic Infections. A Europe-wide assessment of antibiotic resistance rates in Bacteroides and Parabacteroides isolates from intestinal microbiota of healthy subjects. Anaerobe. 2020;62:102182.","journal-title":"Anaerobe"},{"issue":"1","key":"13775_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12866-020-1703-4","volume":"20","author":"W Jamal","year":"2020","unstructured":"Jamal W, Khodakhast FB, AlAzmi A, S\u03ccki J, AlHashem G, Rotimi VO. Prevalence and antimicrobial susceptibility of enterotoxigenic extra-intestinal Bacteroides fragilis among 13-year collection of isolates in Kuwait. BMC Microbiol. 2020;20(1):14.","journal-title":"BMC Microbiol"},{"issue":"12","key":"13775_CR30","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s40265-018-0966-7","volume":"78","author":"S Dhillon","year":"2018","unstructured":"Dhillon S, Meropenem\/Vaborbactam. A Review in Complicated Urinary Tract Infections. Drugs. 2018;78(12):1259\u201370.","journal-title":"Drugs"},{"issue":"1","key":"13775_CR31","first-page":"397","volume":"23","author":"A Hern\u00e1ndez Ceruelos","year":"2019","unstructured":"Hern\u00e1ndez Ceruelos A, Romero-Quezada LC, Ruvalcaba Ledezma JC, L\u00f3pez Contreras L. Therapeutic uses of metronidazole and its side effects: an update. Eur Rev Med Pharmacol Sci. 2019;23(1):397\u2013401.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"13775_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3201\/eid1301.060716","volume":"13","author":"RH Sunenshine","year":"2007","unstructured":"Sunenshine RH, Wright MO, Maragakis LL, Harris AD, Song X, et al. Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis. 2007;13(1):97\u2013103.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"13775_CR33","first-page":"31","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31\u201341.","journal-title":"Nephron"},{"issue":"7","key":"13775_CR34","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/INF.0000000000003911","volume":"42","author":"CA Jackson","year":"2023","unstructured":"Jackson CA, Newland J, Dementieva N, Lonchar J, Su FH, et al. Safety and Efficacy of Ceftolozane\/Tazobactam Plus Metronidazole Versus Meropenem From a Phase 2, Randomized Clinical Trial in Pediatric Participants With Complicated Intra-abdominal Infection. Pediatr Infect Dis J. 2023;42(7):557\u201363.","journal-title":"Pediatr Infect Dis J"},{"issue":"\u2013","key":"13775_CR35","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 2013;48(\u2013):452\u20138.","journal-title":"Bone Marrow Transpl"},{"issue":"2","key":"13775_CR36","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jiac.2020.09.032","volume":"27","author":"S Kohno","year":"2021","unstructured":"Kohno S, Bando H, Yoneyama F, Kikukawa H, Kawahara K, Shirakawa M, Aoyama N, Brown M, Paschke A, Takase A. The safety and efficacy of relebactam\/imipenem\/cilastatin in Japanese patients with complicated intra-abdominal infection or complicated urinary tract infection: A multicenter, open-label, noncomparative phase 3 study. J Infect Chemother. 2021;27(2):262\u201370.","journal-title":"J Infect Chemother"},{"issue":"1","key":"13775_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00000658-200101000-00013","volume":"233","author":"JS Solomkin","year":"2001","unstructured":"Solomkin JS, Wilson SE, Christou NV, Rotstein OD, Dellinger EP, Bennion RS, Pak R, Tack K. Results of a clinical trial of clinafloxacin versus imipenem\/cilastatin for intraabdominal infections. Ann Surg. 2001;233(1):79\u201387.","journal-title":"Ann Surg"},{"key":"13775_CR38","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.2147\/IJGM.S354258","volume":"15","author":"Y Tong","year":"2022","unstructured":"Tong Y, Li Q, Liu S, Liu T, Qu K, Liu C, Zhang J. Antimicrobial and Microbiological Characteristics of Critically Ill Patients with Complicated Intra-Abdominal Infection: Observational Data from Beth Israel Deaconess Medical Center. Int J Gen Med. 2022;15:2127\u201336.","journal-title":"Int J Gen Med"},{"issue":"9","key":"13775_CR39","doi-asserted-by":"publisher","first-page":"102776","DOI":"10.1016\/j.jiac.2025.102776","volume":"31","author":"N Shigemoto","year":"2025","unstructured":"Shigemoto N, Mikamo H, Hata H, Sato J, Matsumoto T, et al. Fourth nationwide surveillance of the antimicrobial susceptibility patterns of pathogens isolated from surgical site infections in Japan. J Infect Chemother. 2025;31(9):102776.","journal-title":"J Infect Chemother"},{"key":"13775_CR40","doi-asserted-by":"crossref","unstructured":"Kajihara T, Yahara K, Kitamura N, Hirabayashi A, Hosaka Y, et al. Distribution, trends, and antimicrobial susceptibility of bacteroides, clostridium, fusobacterium, and prevotella species causing bacteremia in Japan During 2011\u20132020: a retrospective observational study based on national surveillance data. Open Forum Infect Dis. 2023;10(7).","DOI":"10.1093\/ofid\/ofad334"},{"key":"13775_CR41","doi-asserted-by":"publisher","unstructured":"Sawyer RG, Claridge JA, Nathens AB, Rotstein OD, Duane TM, et al. Trial of short-course antimicrobial therapy for intraabdominal infection. N Engl J Med. 2015;372(21):1996\u20132005. https:\/\/doi.org\/10.1056\/NEJMoa1411162. Erratum in: N Engl J Med. 2018;378(7):686.","DOI":"10.1056\/NEJMoa1411162"},{"issue":"4","key":"13775_CR42","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1001\/jamasurg.2015.4236","volume":"151","author":"CC van Rossem","year":"2016","unstructured":"van Rossem CC, Schreinemacher MH, van Geloven AA, Bemelman WA, Snapshot Appendicitis Collaborative Study Group. Antibiotic Duration After Laparoscopic Appendectomy for Acute Complicated Appendicitis. JAMA Surg. 2016;151(4):323\u20139.","journal-title":"JAMA Surg"},{"issue":"2","key":"13775_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000497482","volume":"37","author":"AL van den Boom","year":"2020","unstructured":"van den Boom AL, de Wijkerslooth EML, Wijnhoven BPL. Systematic Review and Meta-Analysis of Postoperative Antibiotics for Patients with a Complex Appendicitis. Dig Surg. 2020;37(2):101\u201310.","journal-title":"Dig Surg"},{"issue":"3","key":"13775_CR44","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1007\/s11605-007-0277-x","volume":"12","author":"A Basoli","year":"2008","unstructured":"Basoli A, Chirletti P, Cirino E, D\u2019Ovidio NG, Doglietto GB, et al. A prospective, double-blind, multicenter, randomized trial comparing ertapenem 3 vs\u2009>\u2009or =\u20095 days in community-acquired intraabdominal infection. J Gastrointest Surg. 2008;12(3):592\u2013600.","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"13775_CR45","doi-asserted-by":"publisher","first-page":"R267","DOI":"10.1186\/cc10545","volume":"15","author":"TC Havey","year":"2011","unstructured":"Havey TC, Fowler RA, Daneman N. Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis. Crit Care. 2011;15(6):R267.","journal-title":"Crit Care"},{"issue":"3","key":"13775_CR46","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s00134-018-5088-x","volume":"44","author":"P Montravers","year":"2018","unstructured":"Montravers P, Tubach F, Lescot T, Veber B, Esposito-Far\u00e8se M, et al. Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial. Intensive Care Med. 2018;44(3):300\u201310.","journal-title":"Intensive Care Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13775-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13775-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13775-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:25:34Z","timestamp":1790238334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13775-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13775"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13775-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol received review and approval from the Ethics Committee of the Japan Community Health Care Organization Kyushu Hospital (Approval No. 1041). Given the retrospective nature of the research, which utilized fully anonymized medical record data, the ethics committee granted an exemption from the requirement to obtain informed consent. All procedures adhered to the principles outlined in the Declaration of Helsinki. As data collection was conducted using de-identified records and did not involve any direct engagement with patients or their guardians, the need for informed consent from legal guardians was formally waived in accordance with the ethical approval.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1483"}}